News | Wearables | October 03, 2022

Mawi launches Mawi Heart Patch

The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice 

The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice

October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring, announced today the official launch of Mawi Heart Patch, the first-ever, single-use 2-lead cardiac monitor to reach the market. A stick-and-go, wireless solution, Mawi Heart Patch improves the detection of cardiovascular diseases, the world’s leading cause of death, by 3x. Providing a detailed report within 24 hours after monitoring is complete, the solution reduces time to diagnosis by 97% and ensures patients get timely access to life-saving treatment. 

Currently, cardiologists rely on Holter monitors made up of multiple wires or multi-use single-lead patches that impact the wearer’s quality of life. These devices are prone to dislodging, peeling and causing allergic reactions, thus restricting monitoring time. As a result, more than 50% of arrhythmias go undetected. Moreover, patients have to wait up to a month to receive the results. Multi-use monitors also require pre- and post-service maintenance, such as changing electrodes and sanitization, before they can be reused, which demands considerable time and resources. These expensive monitors also require significant upfront investment, so facilities typically only have a few available. In limited supply, devices are reserved for a part of those with clear and obvious signs of heart disease, prohibiting those that appear relatively healthy from receiving an early diagnosis before their condition becomes life-threatening. 

The Mawi Heart Patch is the first single-use product to provide an efficient and effective way to detect cardiovascular conditions, enabling healthcare practices to provide timely monitoring to all patients in need. The comfortable, lightweight and discreet sensor can be applied in under 60 seconds and patients can live as normal - work out, take showers and sleep without experiencing discomfort while the AI under the hood powered by a 2-lead ECG technology scans every beat to detect critical abnormalities. This mitigates the ‘white coat effect’ - where the presence of the device skews a patient’s vital metrics - and enables patients to stay relaxed as they go about their routine, making it easier to detect potential problems. Continuously monitoring for up to 7 days, the patch significantly improves the reliability of results with research showing week-long monitoring is x3 more likely to lead to the detection of abnormalities.  

As a single-use product, the patch is fully disposable and doesn’t require any pre- or post-service maintenance, enabling medical facilities to provide large-scale monitoring to all patients showing signs of potentially fatal heart disease. Mawi only charges a fee for service, so practices can scale without initial investment in equipment and software. 

“Cardiovascular diseases pose the greatest risk to our long-term health and are the leading cause of death globally. With a lack of or ineffective monitoring often proving critical, many of these deaths can be avoided with the right preventative measures,” Andrew Klymenko, co-founder of Mawi, said. “Too often, sufferers do not realise the severity of their symptoms before it’s too late. Many patients that use the Mawi Heart Patch look healthy, exercise daily and show no signs of disease, yet have a potentially lethal heart condition. In many cases, conditions aren’t caught in time when relying on outdated cardiac monitors and with lengthy delays to diagnosis. Here, the Mawi Heart Patch is a lifesaver. We’re on a mission to prevent the heart’s ‘silent killers’, and we’re already working with like-minded clinics that are seeing amazing results.” 

For more information: www.mawiheart.com 


Related Content

News | Wearables

July 15, 2025 — Vivalink, a provider of digital healthcare solutions, has announced its wearable ECG monitor is ...

Home July 15, 2025
Home
News | Wearables

July 16, 2024 — Ultrahuman, a pioneer in wearable technology, launches PowerPlugs, a platform for individual apps and ...

Home July 16, 2024
Home
News | Wearables

July 15, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of ...

Home July 15, 2024
Home
News | Wearables

April 12, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of ...

Home April 12, 2024
Home
News | Wearables

February 20, 2024 — X-trodes, a bio-convergence company bringing wireless monitoring solutions to the home environment ...

Home February 20, 2024
Home
News | Wearables

January 3, 2024 — iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted ...

Home January 03, 2024
Home
News | Wearables

December 1, 2023 — As the use of wearable technology grows, smartwatches are marketed across the globe to consumers as a ...

Home December 01, 2023
Home
News | Wearables

November 15, 2023 — Ventric Health, a healthcare technology company and medical device provider focused on ...

Home November 15, 2023
Home
News | Wearables

September 27, 2023 — iRhythm Technologies, Inc. announced the U.S. launch of its next-generation Zio monitor and ...

Home September 27, 2023
Home
News | Wearables

September 19, 2023 — SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud ...

Home September 19, 2023
Home
Subscribe Now